PDE5 inhibition reduces cancer stem cells’ maintenance via induction of PKA signaling [14], cancer cell growth, and tumor immunity through activating cGMP/PKG signaling to block Wnt/β-catenin transcription [15]. This evidence concerns the gene PDE5A and cancer.